US 11306088
CXCR4 inhibitors and uses thereof
granted A61PA61P35/00
Quick answer
US patent 11306088 (CXCR4 inhibitors and uses thereof) held by X4 Pharmaceuticals, Inc. expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P35/00